Stock Price Quote

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis
BSE1747.20-30.25 (-1.7 %)
PREV CLOSE ( ) 1777.45
OPEN PRICE ( ) 1769.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9605
TODAY'S LOW / HIGH ( )1713.00 1769.90
52 WK LOW / HIGH ( )1209.25 1935
NSE1746.45-31.15 (-1.75 %)
PREV CLOSE( ) 1777.60
OPEN PRICE ( ) 1765.00
BID PRICE (QTY) 1746.45 (918)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 303191
TODAY'S LOW / HIGH( ) 1712.40 1768.00
52 WK LOW / HIGH ( )1209.25 1933.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-11 2000
Management Info
Sushil Kanubhai Shah - Chairman Ameera Sushil Shah - Managing Director
Registered Office

Address 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022 6258 2810 / 8422 801 801

Email support@metropolisindia.com / secretarial@metropolisindia.com

Website www.metropolisindia.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

15Apr Announcement under Regulation 30 (LOD
Intimation of allotment of equity shares under Metropolis Healthcare Lim..
12Apr Metropolis Healthcare reports 15% grow
Metropolis Healthcare has reported around 15% growth Year-on-Year (Y-o-Y..
12Apr Metropolis Healthcare soars on reporti
Metropolis Healthcare is currently trading at Rs. 1883.30, up by 83.95 p..
14Mar Metropolis Healthcare informs about di
Metropolis Healthcare has informed that the exchange has received the di..
05Mar Metropolis Healthcare informs about di
Pursuant to Regulation 30 of the Listing Regulations read with SEBI Circ..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit266.971389.46
Gross Profit 346.31 1789.44
Operating Profit 640.142905.92
Net Sales 2694.0910660.41

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE)
peergroup  3337.00 (2.22%)
M.Cap ( in Cr)1568.39
Kovai Medical Center (BSE)
peergroup  3973.60 (1.58%)
M.Cap ( in Cr)4348.02
Jupiter Life Line (BSE)
peergroup  1258.40 (2.87%)
M.Cap ( in Cr)8250.83
Apollo Hospital Ent. (BSE)
peergroup  6334.00 (0.49%)
M.Cap ( in Cr)91073.20
Vijaya Diagnostic (BSE)
peergroup  684.85 (2.30%)
M.Cap ( in Cr)7009.14

Shareholding Pattern

NON-INSTITUTION 7.87%
PROMOTERS 49.74%
FI/BANKS/INSURANCE 4.27%
MUTUAL FUNDS/UTI 16.01%
GOVERNMENT 0%
FII 0%

About Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd. was incorporated in the year 2000. Its today's share price is 1747.2. Its current market capitalisation stands at Rs 8950.7 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10660.41 Cr and Total Income of Rs.10897.57 Cr. The company's management includes Subramanian Ranganathan, Hemant Sachdev, Anita Ramachandran, Sanjay Bhatnagar, Vivek Gambhir, Ameera Sushil Shah, Sushil Kanubhai Shah, Kamlesh Kulkarni.

It is listed on the BSE with a BSE Code of 542650 , NSE with an NSE Symbol of METROPOLIS and ISIN of INE112L01020. It's Registered office is at 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,WorliMumbai-400030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.